Early rituximab treatment in children with idiopathic nephrotic syndrome.
MULTICENTER, RANDOMIZED, DOUBLE-BLIND CLINICAL TRIAL
We invite you to participate in the non-commercial, multicenter, randomized, double-blind, placebo-controlled Phase III clinical trial called ERICONS (Early RITUXIMAB in Childhood Onset Nephrotic Syndrome), which aims to evaluate the duration of disease remission in the treatment group compared to placebo.
In case of technical problems,
BioStat Sp. z o.o.
ul. Kowalczyka 17, 44-206 Rybnik
tel: +48 666 069 834
email: [email protected]
Log in to the eCRF system